Pasteurised Donor Human Milk Supplementation for Term Babies

Recruiting now · Phase 4

Conditions studied: Neonatal Hypoglycemia, Metabolic Complication, Cows Milk Allergy, Hospital Length of Stay, Neonatal Intensive Care Unit, Breastfeeding, Mental Health Issue

In brief

PRESENT is a multi-center randomised controlled trial that aims to assess whether access to pasteurized donor human milk as supplementary nutrition in the first five days of life for term infants born to women with diabetes in pregnancy reduces the proportion of infants who are admitted to a neonatal unit for management of hypoglycemia compared with current standard hospital care. The trial will also assess other important outcomes including breastfeeding rates, maternal mental health, and infant cow's milk allergy. There will be two treatment arms. In the intervention arm, PDHM will be made available to infants from randomisation until day 5 of life. Infants allocated to the control arm will receive care as per local unit policy, including supplemental nutrition as recommended by the treating clinician. After hospital discharge, participants will be asked to complete an electronic questionnaire at 2 \& 6 weeks and 6 \& 12 months after birth. Questionnaires will assess infant feeding practices, maternal quality of life \[including anxiety and depression symptoms and health-related quality of life\] along with infant cow's milk allergy symptoms.

Key facts

Study ID

NCT06993103

Run by

The University of Queensland

People needed

1444

Starts

2025-12-04

Expected to finish

2028-12-01

Last updated by the study team

2026-02-02

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Each participant must meet all the following criteria to be enrolled in this trial:
• Mother is >18 years at the time of consent
• Mother has diabetes in pregnancy (type 1, type 2 or gestational diabetes)
• Mother intends to breastfeed for at least 6 weeks at the time of consent.
• Infant is born at ≥ 37 weeks and weighs > 2.5kg
• Clinician caring for infant decides that supplementary nutrition (in addition to maternal breast milk) is required within the first 48 hours after birth.
• Parent/s provide/s a signed and dated informed consent form and has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf.

You may not qualify if…

• Mother/infant pairs meeting any of the following criteria will be excluded from the trial:
• Multiple pregnancy
• Mother has a condition that precludes maternal breast milk consumption e.g. HIV, receiving chemotherapy
• Infant has clinically significant congenital abnormality interfering with effective breastfeeding or breast milk consumption (e.g., cleft lip and palate, metabolic disorder) and/or requiring immediate care in a neonatal unit (e.g., congenital heart disease).
• Infant has received infant formula prior to randomisation.
• Infant admitted to neonatal intensive care prior to randomisation.
• More than 48 hours old at the time of recruitment

Where it is running

• Royal Womens Hospital (VIC) — Melbourne, Victoria, Australia (enrolling)
• Royal Brisbane and Womens Hospital (QLD) — Brisbane, Queensland, Australia
• Greenslope Hospital (QLD) — Brisbane, Queensland, Australia
• Frances Perry House (VIC) — Melbourne, Victoria, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.